Filing Details
- Accession Number:
- 0001209191-10-016615
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-12 12:00:00
- Reporting Period:
- 2010-03-10
- Filing Date:
- 2010-03-12
- Accepted Time:
- 2010-03-12 16:12:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887359 | Aastrom Biosciences Inc | ASTM | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1194712 | Jr W George Dunbar | P.o. Box 376 Ann Arbor MI 48106 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-03-10 | 9,000 | $1.56 | 12,750 | No | 4 | P | Indirect | By the George & Lucy Dunbar Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By the George & Lucy Dunbar Trust |
Footnotes
- The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.56, inclusive. The reporting person undertakes to provide Aastrom Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
- Reflects a 1-for-8 reverse stock split which became effective on February 18, 2010.
- These shares are held in a trust for the benefit of the reporting person's children. The reporting person and the reporting person's spouse are trustees of the trust. These shares were previously reported as direct holdings in error. The filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.